Insurance Companies to Be Blocked From Using Genetic Information
Federal law already prevents health insurers from using genetic information in underwriting policies and in setting premiums. But the prohibition doesn't apply to life insurance or long-term care coverage.
March 13, 2020 at 01:58 PM
3 minute read
Florida lawmakers passed a bill that would block life insurers and long-term care insurers from using genetic information to price policies, making Florida the first state to ban the use of the information.
Bill sponsor and incoming House Speaker Chris Sprowls, R-Palm Harbor, called the unanimous House vote a "major victory for Floridians" and predicted that other states will follow.
"This legislation will also undoubtedly make Florida a model for the rest of the nation for ensuring individuals' genetic information is kept private and that it cannot be used against them by any category of insurers," Sprowls said in a statement.
Federal law already prevents health insurers from using genetic information in underwriting policies and in setting premiums. But the prohibition doesn't apply to life insurance or long-term care coverage, which Sprowls has described as a "massive loophole."
Sprowls said he discovered the issue in December 2017 when he was applying for life insurance. While he was on hold on the telephone waiting for assistance, he said he was struck by commercials from companies such as 23andMe and AncestryDNA encouraging people to buy genetic tests.
The Senate voted 35-3 on Wednesday to approve the bill after adding an amendment that clarified insurers could take into consideration diagnoses in customers' medical records, even if the diagnoses were based on genetic information. Sprowls told The News Service of Florida that the amendment "was a restatement of what the bill already allowed."
The bill now will go to Gov. Ron DeSantis, who can either veto it, allow it to become law without his signature or sign it into law.
In addition to precluding the companies from using genetic information to price policies, the bill would prevent insurers from using the information in making policy decisions. Sprowls' bill also would block the companies from requiring or soliciting genetic information from applicants. The bill also would prevent the use of genetic information by disability insurers.
Senate sponsor Kelli Stargel, R-Lakeland, said the measure protects Floridians who use genetic testing kits.
"While countless Floridians have used DNA testing kits to learn more about their background or identify potential health risks, they didn't sign up in order for insurers to access this personal information and then base their policies on it," Stargel said in a prepared statement. "We are elected to protect Floridians, and this good public policy protects them from insurers invading their private personal DNA data and using it against them."
The American Council of Life Insurers, which had opposed the proposal, did not comment on the bill's final passage. Sprowls is slated to become House speaker after the November elections.
Christine Sexton reports for the News Service of Florida.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllLegionnaires' Disease on Rise in Fla.: Are Property Owners Aware of Dangers to Their Guests?
Trending Stories
Who Got The Work
Dechert partners Andrew J. Levander, Angela M. Liu and Neil A. Steiner have stepped in to defend Arbor Realty Trust and certain executives in a pending securities class action. The complaint, filed July 31 in New York Eastern District Court by Levi & Korsinsky, contends that the defendants concealed a 'toxic' mobile home portfolio, vastly overstated collateral in regards to the company's loans and failed to disclose an investigation of the company by the FBI. The case, assigned to U.S. District Judge Pamela K. Chen, is 1:24-cv-05347, Martin v. Arbor Realty Trust, Inc. et al.
Who Got The Work
Arthur G. Jakoby, Ryan Feeney and Maxim M.L. Nowak from Herrick Feinstein have stepped in to defend Charles Dilluvio and Seacor Capital in a pending securities lawsuit. The complaint, filed Sept. 30 in New York Southern District Court by the Securities and Exchange Commission, accuses the defendants of using consulting agreements, attorney opinion letters and other mechanisms to skirt regulations limiting stock sales by affiliate companies and allowing the defendants to unlawfully profit from sales of Enzolytics stock. The case, assigned to U.S. District Judge Andrew L. Carter Jr., is 1:24-cv-07362, Securities and Exchange Commission v. Zhabilov et al.
Who Got The Work
Clark Hill members Vincent Roskovensky and Kevin B. Watson have entered appearances for Architectural Steel and Associated Products in a pending environmental lawsuit. The complaint, filed Aug. 27 in Pennsylvania Eastern District Court by Brodsky & Smith on behalf of Hung Trinh, accuses the defendant of discharging polluted stormwater from its steel facility without a permit in violation of the Clean Water Act. The case, assigned to U.S. District Judge Gerald J. Pappert, is 2:24-cv-04490, Trinh v. Architectural Steel And Associated Products, Inc.
Who Got The Work
Michael R. Yellin of Cole Schotz has entered an appearance for S2 d/b/a the Shoe Surgeon, Dominic Chambrone a/k/a Dominic Ciambrone and other defendants in a pending trademark infringement lawsuit. The case, filed July 15 in New York Southern District Court by DLA Piper on behalf of Nike, seeks to enjoin Ciambrone and the other defendants in their attempts to build an 'entire multifaceted' retail empire through their unauthorized use of Nike’s trademark rights. The case, assigned to U.S. District Judge Naomi Reice Buchwald, is 1:24-cv-05307, Nike Inc. v. S2, Inc. et al.
Who Got The Work
Sullivan & Cromwell partner Adam S. Paris has entered an appearance for Orthofix Medical in a pending securities class action arising from a proposed acquisition of SeaSpine by Orthofix. The suit, filed Sept. 6 in California Southern District Court, by Girard Sharp and the Hall Firm, contends that the offering materials and related oral communications contained untrue statements of material fact. According to the complaint, the defendants made a series of misrepresentations about Orthofix’s disclosure controls and internal controls over financial reporting and ethical compliance. The case, assigned to U.S. District Judge Linda Lopez, is 3:24-cv-01593, O'Hara v. Orthofix Medical Inc. et al.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250